---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-26-000153"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2026-08-05T20:09:49+00:00"
generated_at: "2026-08-05T20:11:52.967204+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GoodRx appoints Justin Fengler as CFO, replacing Christopher McGinnis

## Summary
- Christopher McGinnis to step down as CFO & Treasurer effective Aug 5, 2026; departure not due to disagreement.
- Justin Fengler, current Chief Strategy & Operations Officer, appointed CFO & Treasurer effective Aug 6, 2026.
- Fengler receives $600k RSU, $600k PSU, $100k cash, and Tier 1 severance plan designation.
- McGinnis expected to receive severance per Tier 1 plan and sign separation agreement with non-disparagement.
- Fengler has been with GoodRx since 2016, previously SVP of Corporate Strategy & Business Operations.

## SEC filing metadata
- accession: 0001809519-26-000153
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2026-08-05T20:09:49+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/0001809519-26-000153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/gdrx-20260731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-26-000153
- JSON: https://secwatch.observer/filing/0001809519-26-000153.json
- Plain text: https://secwatch.observer/filing/0001809519-26-000153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.